



Founded by internationally recognised experts the IDS meeting brings together world leaders working across immune-activated skin conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo and hidradenitis suppurativa.
To capture key perspectives from the 2025 Summit, we spoke with editorial board member, Prof. Dedee Murrell, to bring you some of the key highlights from a selection of standout presentations delivered during the three-day event.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers.
In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
In this interview, Dr Ben Kaffenberger discusses late-breaking Phase 3 data on vilobelimab for pyoderma gangrenosum, presented at AAD 2026. Building on promising Phase 2 results, the trial evaluates its efficacy in an indication with no approved treatments in the USA or Europe. These findings may mark an important step toward potential FDA approval and improved outcomes for patients with this severe disease.
Dr Melinda Gooderham discusses the phase 3 LATITUDE trial results for zasocitinib, exploring the depth and speed of clinical responses observed and what these findings could mean for the future management of moderate-to-severe plaque psoriasis.
Your clinical career is shaped not only by what you know, but by who helps you navigate what comes next. Join us for the final episode in our LEADderm mini-series exploring non-clinical skills that can help you thrive in your ...
Join us as leading experts discuss key data and perspectives from the late-breaking sessions at this year’s AAD meeting This March, experts from around the world gathered in Denver, Colorado, for the 2026 American Academy of Dermatology (AAD) Annual Meeting. ...
Founded by internationally recognised experts the IDS meeting brings together world leaders working across immune-activated skin conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo and hidradenitis suppurativa. To capture key perspectives from the 2025 Summit, we spoke with editorial board member, Prof. Dedee Murrell, to bring you some of the key highlights from a selection of standout presentations delivered during the three-day event.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
Share your knowledge, influence clinical practices and enhance patient care in Dermatology today!
Editors-in-Chief Professor Tiago Torres and Dr Raj Chovatiy, will lead touchREVIEWS in Dermatology, our platform's forthcoming free-to-access, peer-reviewed journal. Committed to improving patient outcomes, the journal aims to support healthcare professionals and researchers worldwide in the continuous development of their knowledge and confidence to enhance patient care, drive meaningful change in clinical practice, and promote equity in healthcare globally.
As the field of dermatology continues to evolve at pace, the questions shaping its future are no longer confined to new drugs or devices. Looking ahead, we asked our Future Leaders of 2025 a question: which emerging trend or topic deserves greater attention in 2026? Their responses collectively offer a snapshot of the conversations poised to shape the specialty in the year ahead, highlighting challenges that extend beyond scientific innovation alone.
Money is something we all have to navigate, but it is not always something we are taught to understand or manage, nor necessarily something we connect with building a fulfilling career in medicine. In the second episode of our LEADderm mini-series, we are joined by two US-based clinicans: dermatologist and LEADderm Founder Dr Jennifer Soung, and Dr Bonnie Koo, Founder of Wealthy Mom MD and author of Defining Wealth for Women: Peace, Purpose, and Plenty of Cash, for an honest conversation about financial confidence and redefining wealth. Together, we explore how shifting our mindset around money can create greater freedom, choice and resilience, helping healthcare professionals feel more grounded so that they can thrive in their clinical careers and beyond.
Whether you’re working in an agency, in a clinical role, or in academia, many healthcare professionals wonder what lies behind the doors of the pharmaceutical industry. In this episode, Gina is joined by Sian Kneller, Director of Global Content Design at GSK and Founder of The Agency Advantage, to unpack exactly what it takes to make the leap. With over 20 years’ experience, from medical writer to leading global medical affairs strategy, Sian now helps others make a successful move into pharma. In this episode she shares what the transition really looks like, which transferable skills matter most, and how you can stand out in a competitive field.
SPINK5-sEDD, a syndromic epidermal differentiation disorder formerly known as Netherton syndrome, is the focus of this latest instalment in our rare disease round-up series, which highlights advances in diagnosing and managing uncommon dermatological conditions. In this Q&A, Dr Pablo López Balboa – a paediatric dermatologist specialising in complex and rare skin diseases – discusses the evolving understanding of SPINK5-sEDD, from its characteristic clinical triad and neonatal presentation to the underlying protease-driven pathology and emerging therapeutic strategies.
Laser and energy based devices are transforming dermatology, offering increasingly advanced ways to treat a wide range of conditions from pigment disorders and tattoo removal to skin rejuvenation and aesthetic enhancement. As the technology evolves, so too does our understanding of how to use it most effectively in clinical practice. At the same time, the field faces significant challenges, including the influence of marketing and the importance of selecting these technologies appropriately.
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
In this episode, we speak with leading paediatric allergist Prof. Helen Brough to explore the key factors behind why some children develop allergies to foods such as peanuts, and what we can do to help prevent them. We also examine the latest developments in managing food allergies and the innovations on the horizon that could transform how we treat them.
Onychomycosis is one of the most common nail conditions seen in clinical practice, yet diagnosis is often uncertain and treatment failures are frustratingly common. In this episode, Dr Shari Lipner shares practical updates on smarter diagnostics, existing & emerging therapies, and what we need to know about how to manage this condition today and in the future.
The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Could targeting hair follicle stem cells be the key to reversing, and even preventing, age-related hair loss? In this episode, we’re joined by Dr Jon Edelson to explore a novel approach that could address the root cause of age-related hair loss. With no new approved treatments in decades, this cutting-edge strategy could represent a major leap forward. Tune in as we discuss the science behind stem cell reactivation and how it could reshape the future of hair restoration for the millions of men and women affected by this form of hair loss.
Watch four dermatology experts explore the evolving science of type 2 inflammation in a series of videos originally presented at the March 2025 ADVENT symposium in Orlando, Florida.
This year, we are celebrating our inaugural touchDERMATOLOGY Future Leaders to recognize the outstanding talent that has entered our field in recent years. These individuals are set to innovate and transform dermatology in the years to come.
Representing a diverse range of expertise from across the globe, these highly accomplished clinicians are among the brightest minds shaping the future of dermatology. We had the pleasure of learning about their unique career journeys, motivations and the inspirations that have guided their paths. They also shared their perspectives on the most exciting developments in dermatology today, along with their hopes for the future of the field.
Dr Antoni Gostyński is advancing the field of dermatology through his work on innovative diagnostic tools and therapeutic strategies.
Based at Maastricht University Medical Centre, Dr Gostyński co-leads the hereditary skin diseases clinic and also practises at the Catharina Hospital in Eindhoven. His clinical and research interests centres on genodermatoses, particularly ichthyoses amd palmoplantar keratodermas, and he actively collaborates with national patient advocacy groups to support those living with these rare genetic conditions.
“…what excites me the most is the intersection of genetics and immunology, really looking into the molecular pathways and understanding the pathological mechanisms of disease…”
Dr Tashmeeta Ahad, a Clinical Assistant Professor and Consultant Dermatologist at the University of British Columbia and clinician-scientist at the Photomedicine Institute, Vancouver Coastal Health Research Institute, is an emerging leader in dermatology.
Her research and clinical interests include developing optical biopsy techniques for monitoring skin cancer treatment, studying photosensitivity disorders, and applying laser, photodynamic therapy and phototherapy to manage a range of skin conditions.
“No two days are ever the same, and that constant variety is something I truly value.”
Dr Alicia Little, Assistant Professor at Yale School of Medicine and Director of the Yale Vulvar Dermatology Clinic, is recognised for her expertise in women’s skin health and autoimmune skin diseases.
Her clinical focus includes treating complex conditions including vulvar skin disorders, cutaneous lupus, dermatomyositis, morphea, lichen sclerosus and lichen planus. In parallel, her research explores the cellular mechanisms underlying autoimmune skin diseases to identify new therapeutic targets and improve patient outcomes.
“If I can play even a small part in breaking that silence, reducing the stigma, progressing the discussion and hopefully pushing the science forward, that would feel like a huge success.”
Dr Ho is a Consultant Dermatologist and Dermatopathologist at the University Hospital of the West Indies. His clinical and academic interests include complex medical dermatology, autoimmune blistering diseases and cutaneous malignancies.
Dr Ho researches disease patterns in Jamaica’s predominantly Afro-Caribbean population and has published widely in clinical dermatology and dermatopathology. A dedicated educator, he also plays a key role in training and mentoring the next generation of dermatologists.
“Try to find a mentor who inspires you, who can guide you and perhaps help you do some research.”
Dr Zenas Yiu, University of Manchester, UK, is recognized for his contributions to dermatological research and commitment to advancing evidence-based care in inflammatory skin disease.
He specialises in dermato-epidemiology and pharmacoepidemiology, focusing on evaluating new treatments for chronic inflammatory skin conditions. In addition to contributing to national clinical guidelines and health technology appraisals, he mentors PhD students and clinical fellows as part of his academic leadership.
“I have found it hugely rewarding to be able to build up a long term relationship and rapport with some of my patients, and nothing beats seeing them get better and flourishing.”
Introducing the Expert Faculty of touchDERMATOLOGY, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.

Inflammatory & autoimmune diseases

Dr Shawn Kwatra is the Joseph W. Burnett Endowed Professor and Chairman of Dermatology at the University of Maryland School of Medicine in Baltimore, MD, USA. He is an internationally renowned dermatologist and clinical leader in skin of colour research, as well as chronic inflammatory skin diseases, including atopic dermatitis, prurigo nodularis, and chronic pruritus of unknown origin. Dr Kwatra also has expertise in managing cutaneous adverse events associated with immunotherapy. Dr Kwatra has been an author or co-author on over 270 publications in peer-reviewed international journals and is a member of several professional organizations, including the American Academy of Dermatology, the Society for Investigative Dermatology, the International Forum for the Study of Itch and is currently serving on the Board of Directors of the Skin of Color Society.

Inflammatory & autoimmune diseases

Associate Professor, Rosalind Franklin University Chicago Medical School, Chicago, IL, USA
Raj Chovatiya, MD, PhD, MSCI is Clinical Associate Professor of Medicine at Rosalind Franklin University Chicago Medical School and Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago, Illinois. His clinical and research focus includes the intersection of cutaneous immunology and inflammatory disease. He received his MD and PhD in immunology from Yale and completed his residency, postdoctoral research fellowship, and MS in Clinical Investigation at Northwestern University where he also served as Chief Resident. Dr. Chovatiya has a particular interest in optimizing patient-centered care, understanding chronic disease burden especially in understudied inflammatory diseases, exploring health and social disparities, and improving care across diverse skin types. He has published numerous abstracts and manuscripts and has been nationally and internationally recognized for his contributions as a clinician, educator, researcher, and leader.

Inflammatory & autoimmune diseases; Acne

Professor and Head of Department of Dermatology, St George Hospital, University of NSW, Australia
Professor Dedee Murrell completed medical training at Cambridge and Oxford Universities, 3 years of internal medicine in the UK and USA, dermatology training at UNC-Chapel Hill, a fellowship in dermatopharmacology at Duke, blistering diseases and cell biology at New York University, and then became a clinical scholar at Rockefeller University. She holds a doctorate on the pathogenesis of blistering disorders, her main subspecialty interest, and her current research focusses on the development and validation of clinical outcome measures for autoimmune blistering diseases and epidermolysis bullosa to enable clinical trials to proceed in these orphan diseases. She has 418 peer reviewed papers, 16,7500 citations, an H index of 61, i!) of 213 and has edited 6 books, including the textbook, Blistering Diseases. She lectures at international congresses regularly and is a visiting professor in 5 continents. She was Congress President of the ICD 2021, the world’s first virtual Dermathon. She was founding Co-Editor of the International Journal of Women’s Dermatology and serves on the editorial boards of BJD, JAMA Dermatology, International Journal of Dermatology, JEADV, Acta Dermatovenereologica and JAAD International. She established Australia’s first dedicated dermatology clinical trial centre and is a KOL in trial design and conduct, serving on numerous advisory boards for more than 20 years. Her group established the ABQOL/TABQOL for measuring QOL in AIBD and she co-led the development and validation of the PDAI, BPDAI and MMPDAI. She established the Australasian Blistering Diseases Foundation in 2006.

Inflammatory & autoimmune diseases

Assistant Professor of Dermatology at Yale School of Medicine, New Haven, CT, USA
William Damsky, MD, PhD is an Assistant Professor of Dermatology at Yale School of Medicine and board-certified dermatologist and dematopathologist. In clinical practice, he specializes in evaluation and treatment of patients with inflammatory skin disorders, especially cutaneous granulomatous diseases such as sarcoidosis and granuloma annulare. Dr. Damsky is interested in the identification and evaluation of new treatment approaches for inflammatory skin disease and conducts clinical trials in this area. As a physician-scientist with training in basic immunology, Dr. Damsky’s laboratory leverages the latest immunologic approaches to understand mechanisms of inflammatory skin disease and how they are affected by novel therapies. Dr. Damsky’s research has been supported by Career Development Awards from the Dermatology Foundation and the National Institute of Allergy and Infectious Diseases (NIAID). He was awarded the 2020 Young Investigator Award by the American Academy of Dermatology for his research in novel therapeutics for sarcoidosis.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.